Valeant Pharmaceuticals International Inc. has received U.S. Food and Drug Administration approval for Relistor tablets to treat opioid-induced constipation for patients with noncancer pain.
from WSJ.com: US Business http://ift.tt/2ashCQ2
via IFTTT
No comments:
Post a Comment